Alzheimer's disease genetic testing offers insights into an individual's predisposition to developing this form of dementia. It involves examining specific genes such as APOE-e4, which can influence the likelihood of Alzheimer's onset. While genetic testing can provide valuable information, it doesn't guarantee that someone will develop the disease, as other factors like lifestyle and environment also play significant roles.
Ethical concerns surround the testing, including issues of privacy, psychological impact of knowing one's genetic risk, and the lack of effective treatments even if a predisposition is identified. As research advances, genetic testing may become more precise and informative, potentially aiding in early intervention or personalized treatments. However, current recommendations advise careful consideration before pursuing genetic testing, emphasizing the importance of genetic counseling to understand the implications and make informed decisions.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China